2 completed. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow Laron Syndrome: new trials by email Literature Review of Laron Syndrome trials Research Report on Laron Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Term Treatment With rhIGF-1 in GHIS mecasermin - Growth Hormone Insensitivity Syndrome | Phase 2 / Phase 3 | Completed | Ipsen | 92 | 1991-05-20 | 2023-07-06 |
| IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome rhIGF-I/rhIGFBP-3 - Growth Hormone Insensitivity Syndrome (GHIS), Laron Syndrome | Phase 2 / Phase 3 | Completed | Insmed Incorporated | 2012-09-13 |
Bone Diseases (2) · Bone Diseases, Developmental (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Dwarfism (2) · Endocrine System Diseases (2) · Genetic Diseases, Inborn (2) · Musculoskeletal Diseases (2)
Insulin-Like Growth Factor I (1) · mecasermin (1)
Insmed Incorporated (1) · Ipsen (1)
United States (2) · Argentina (1) · Australia (1) · Brazil (1) · China (1) · Egypt (1) · Germany (1) · Israel (1) · Italy (1) · Norway (1) · Peru (1) · Slovakia (1) · Turkey (Türkiye) (1) · United Kingdom (1)